Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
David Spector
Cold Spring Harbor Laboratory, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Ionis Pharmaceuticals
Other : Consulting fees and research collaborator
A FCOI #4962 with ISIS Pharmaceuticals was originally initiated in April 2013. The company (ISIS) changed its name due to the negative connotations of its name and it is now called Ionis Pharmaceuticals. The FCOI remains the same, but it has the name change to Ionis Pharmaceuticals. This FCOI report entry documents the company's name change from ISIS Pharmaceuticals to Ionis Pharmaceuticals. Ionis still provides Dr. Spector with reagents for a research project that focuses on a molecule that is in the aforementioned grant.
Cold Spring Harbor Laboratory Cancer Research Center
PROJECT NARRATIVE - OVERALL Despite decades of research, cancer claims more than half a million lives in the US each year. Using innovative approaches and cutting edge technology, this Program Project aims to understand how basic cellular processes are altered as normal cells become cancerous. The insights gained through this research are likely to reveal highly specific, new vulnerabilities in cancer cells that will be the basis of innovative drug development in the fight against cancer.
Filed on March 26, 2018.
Tell us what you know about David Spector's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “David Spector”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| David Spector | Cold Spring Harbor Laboratory | Conflict of Interest | ISIS Pharmaceuticals | $40,000 - $59,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.